# BMP6

## Overview
Bone morphogenetic protein 6 (BMP6) is a protein encoded by the BMP6 gene, which is a member of the transforming growth factor-beta (TGF-beta) superfamily. This protein plays a pivotal role in bone and cartilage development, functioning as a growth factor that influences the differentiation of mesenchymal stem cells into osteoblasts and chondrocytes. BMP6 is synthesized as a precursor molecule that undergoes post-translational modifications, including cleavage and glycosylation, to become active. It forms dimers, which can be either homodimers or heterodimers, and interacts with specific receptors to initiate signaling pathways that regulate cellular proliferation, differentiation, and apoptosis. Beyond its role in skeletal development, BMP6 is involved in systemic metabolic processes, such as iron and glucose metabolism, and has been implicated in various clinical conditions, including iron overload disorders and bone development anomalies (Bragdon2011Bone; Vukicevic2009BMP6).

## Structure
BMP6 is a member of the TGF-beta superfamily and is involved in bone and cartilage development. The protein is synthesized as a large precursor molecule, which includes an N-terminal signal peptide, a prodomain for proper folding, and a C-terminal mature peptide. The mature BMP6 protein is cleaved from the prodomain at a specific Arg-X-X-Arg sequence by serine endoproteases such as Furin, PC6, and PC7 (Bragdon2011Bone).

The primary structure of BMP6 consists of a sequence of amino acids forming a precursor protein. The secondary structure includes alpha-helices and beta-sheets, which fold into a three-dimensional shape stabilized by disulfide bonds, forming a cysteine knot motif. This motif is crucial for the stabilization of the dimer through an intermolecular cystine bridge (Carreira2014Bone).

In its quaternary structure, BMP6 forms dimers, which can be either homodimers or heterodimers. Heterodimers, such as BMP2/6, are noted to be more effective activators of signaling pathways (Bragdon2011Bone). Post-translational modifications, including N-glycosylation, are essential for BMP6's interaction with its receptors, such as ActR-I (Bragdon2011Bone). These modifications enhance the protein's stability and receptor specificity (Carreira2014Bone).

## Function
Bone morphogenetic protein 6 (BMP6) is a member of the TGF-beta superfamily and plays a significant role in various cellular processes, particularly in bone and cartilage development. BMP6 is involved in the differentiation of mesenchymal stem cells into osteoblasts, which are crucial for bone formation and remodeling. It stimulates the expression of alkaline phosphatase and osteocalcin, markers of osteoblastic differentiation, and enhances bone formation in mesenchymal stem cell cultures (Sammons2004The; Vukicevic2009BMP6).

In chondrocytes, BMP6 promotes maturation by accelerating the expression of type X collagen, a marker of chondrocyte hypertrophy, and enhances alkaline phosphatase activity, indicating its role in chondrocyte differentiation and cartilage maintenance (Grimsrud1999BMP6). BMP6 also stimulates proteoglycan synthesis in articular chondrocytes, contributing to cartilage matrix synthesis and potentially aiding in cartilage repair (Bobacz2003Expression).

BMP6 is active in the extracellular matrix, where it influences signaling pathways that regulate cellular functions and tissue homeostasis. It binds to type I and type II BMP receptors, initiating signaling cascades that affect cell proliferation, differentiation, and apoptosis (Ahmed2001EFFECT). BMP6's role extends beyond bone and cartilage, as it is also involved in systemic metabolic processes, including iron and glucose metabolism (Vukicevic2009BMP6).

## Clinical Significance
Mutations and alterations in the BMP6 gene are associated with several clinical conditions, particularly those related to iron metabolism and bone development. BMP6 plays a crucial role in systemic iron regulation through the BMP/SMAD signaling pathway, which affects hepcidin transcription. Mutations in BMP6 can lead to iron overload conditions similar to hereditary hemochromatosis, characterized by low hepcidin levels and excessive iron accumulation. This can result in liver cirrhosis, diabetes, and other complications (Alvarenga2020Novel).

In bone development, BMP6 is essential for proper ossification and skeletal formation. BMP6 knockout mice exhibit delayed skeletal development and reduced ossification of the sternum, indicating its importance in bone health (Salazar2016BMP; Wang2014Bone). BMP6 also influences glucose metabolism, with its absence potentially leading to diabetes due to iron accumulation in pancreatic beta cells (Vukicevic2009BMP6).

While BMP6 is implicated in various conditions, its role in glaucoma remains unclear. A study found no significant association between BMP6 polymorphisms and primary angle-closure glaucoma or pseudoexfoliation glaucoma in a Saudi population (Kondkar2020Association). Overall, BMP6 mutations and expression alterations are linked to significant metabolic and developmental disorders.

## Interactions
BMP6 interacts with various receptors and molecules, playing a significant role in bone morphogenesis and cellular signaling. It primarily binds to type I receptors such as ACVR1A and type II receptors like ACVR2A, forming complexes that activate downstream signaling pathways, including the phosphorylation of Smad proteins (Lavery2008BMP24). BMP6 can also form ternary complexes with receptors, similar to BMP-2, indicating comparable receptor-binding interfaces (Allendorph2007BMP-3).

BMP6's interaction with heparin and heparan sulfate (HS) is notable, as these glycosaminoglycans inhibit its biological activity. Heparin binds to BMP6 through specific arginine- and lysine-rich clusters, known as heparin-binding domains (HBDs), which are crucial for the interaction. This binding inhibits BMP6-induced Smad1/5/8 phosphorylation and osteogenic activity, potentially contributing to heparin-induced osteoporosis (Denardo2021BMP6; Brkljacic2013Exogenous). The interaction is mediated by electrostatic and hydrophobic interactions, with specific residues playing key roles in binding affinity (Denardo2021BMP6). These interactions highlight BMP6's complex regulatory mechanisms in bone formation and its potential therapeutic implications.


## References


[1. (Denardo2021BMP6) Andrea Denardo, Stefano Elli, Stefania Federici, Michela Asperti, Magdalena Gryzik, Paola Ruzzenenti, Fernando Carmona, Paolo Bergese, Annamaria Naggi, Paolo Arosio, and Maura Poli. Bmp6 binding to heparin and heparan sulfate is mediated by n-terminal and c-terminal clustered basic residues. Biochimica et Biophysica Acta (BBA) - General Subjects, 1865(2):129799, February 2021. URL: http://dx.doi.org/10.1016/j.bbagen.2020.129799, doi:10.1016/j.bbagen.2020.129799. This article has 10 citations.](https://doi.org/10.1016/j.bbagen.2020.129799)

[2. (Wang2014Bone) Richard N. Wang, Jordan Green, Zhongliang Wang, Youlin Deng, Min Qiao, Michael Peabody, Qian Zhang, Jixing Ye, Zhengjian Yan, Sahitya Denduluri, Olumuyiwa Idowu, Melissa Li, Christine Shen, Alan Hu, Rex C. Haydon, Richard Kang, James Mok, Michael J. Lee, Hue L. Luu, and Lewis L. Shi. Bone morphogenetic protein (bmp) signaling in development and human diseases. Genes &amp; Diseases, 1(1):87–105, September 2014. URL: http://dx.doi.org/10.1016/j.gendis.2014.07.005, doi:10.1016/j.gendis.2014.07.005. This article has 761 citations.](https://doi.org/10.1016/j.gendis.2014.07.005)

[3. (Brkljacic2013Exogenous) Jelena Brkljacic, Martina Pauk, Igor Erjavec, Antonio Cipcic, Lovorka Grgurevic, Renata Zadro, Gareth J. Inman, and Slobodan Vukicevic. Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity. International Orthopaedics, 37(3):529–541, January 2013. URL: http://dx.doi.org/10.1007/s00264-012-1714-3, doi:10.1007/s00264-012-1714-3. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00264-012-1714-3)

[4. (Allendorph2007BMP-3) George P. Allendorph, Michael J. Isaacs, Yasuhiko Kawakami, Juan Carlos Izpisua Belmonte, and Senyon Choe. Bmp-3 and bmp-6 structures illuminate the nature of binding specificity with receptors,. Biochemistry, 46(43):12238–12247, October 2007. URL: http://dx.doi.org/10.1021/bi700907k, doi:10.1021/bi700907k. This article has 139 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi700907k)

[5. (Ahmed2001EFFECT) N. Ahmed, J. Sammons, R. J. Carson, M. A. Khokher, and H. T. Hassan. Effect of bone morphogenetic protein‐6 on haemopoietic stem cells and cytokine production in normal human bone marrow stroma. Cell Biology International, 25(5):429–435, May 2001. URL: http://dx.doi.org/10.1006/cbir.2000.0662, doi:10.1006/cbir.2000.0662. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/cbir.2000.0662)

[6. (Bobacz2003Expression) K. Bobacz, R. Gruber, A. Soleiman, L. Erlacher, J. S. Smolen, and W. B. Graninger. Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis &amp; Rheumatism, 48(9):2501–2508, September 2003. URL: http://dx.doi.org/10.1002/art.11248, doi:10.1002/art.11248. This article has 72 citations.](https://doi.org/10.1002/art.11248)

[7. (Vukicevic2009BMP6) Slobodan Vukicevic and Lovorka Grgurevic. Bmp-6 and mesenchymal stem cell differentiation. Cytokine &amp; Growth Factor Reviews, 20(5–6):441–448, October 2009. URL: http://dx.doi.org/10.1016/j.cytogfr.2009.10.020, doi:10.1016/j.cytogfr.2009.10.020. This article has 110 citations.](https://doi.org/10.1016/j.cytogfr.2009.10.020)

[8. (Alvarenga2020Novel) Aline Morgan Alvarenga, Nathália Kozikas da Silva, Paula Fernanda Silva Fonseca, Theo G.M. Oliveira, Jacilene Barbosa da Silva Monteiro, Rodolfo Delfini Cançado, Flavio Augusto Naoum, Carla Luana Dinardo, Pierre Brissot, and Paulo Caleb Junior Lima Santos. Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the hfe p.cys282tyr mutation. Blood Cells, Molecules, and Diseases, 84:102444, September 2020. URL: http://dx.doi.org/10.1016/j.bcmd.2020.102444, doi:10.1016/j.bcmd.2020.102444. This article has 7 citations.](https://doi.org/10.1016/j.bcmd.2020.102444)

[9. (Lavery2008BMP24) Karen Lavery, Pamela Swain, Dean Falb, and Moulay Hicham Alaoui-Ismaili. Bmp-2/4 and bmp-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Journal of Biological Chemistry, 283(30):20948–20958, July 2008. URL: http://dx.doi.org/10.1074/jbc.M800850200, doi:10.1074/jbc.m800850200. This article has 358 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M800850200)

[10. (Grimsrud1999BMP6) Christopher D. Grimsrud, Paul R. Romano, Mary D’souza, J. Edward Puzas, Paul R. Reynolds, Randy N. Rosier, and Regis J. O’keefe. Bmp-6 is an autocrine stimulator of chondrocyte differentiation. Journal of Bone and Mineral Research, 14(4):475–482, April 1999. URL: http://dx.doi.org/10.1359/jbmr.1999.14.4.475, doi:10.1359/jbmr.1999.14.4.475. This article has 147 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1359/jbmr.1999.14.4.475)

[11. (Kondkar2020Association) Altaf A. Kondkar, Tahira Sultan, Taif A. Azad, Essam A. Osman, Faisal A. Almobarak, and Saleh A. Al-Obeidan. Association analysis of polymorphisms rs12997 in acvr1 and rs1043784 in bmp6 genes involved in bone morphogenic protein signaling pathway in primary angle-closure and pseudoexfoliation glaucoma patients of saudi origin. BMC Medical Genetics, July 2020. URL: http://dx.doi.org/10.1186/s12881-020-01076-0, doi:10.1186/s12881-020-01076-0. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12881-020-01076-0)

[12. (Salazar2016BMP) Valerie S. Salazar, Laura W. Gamer, and Vicki Rosen. Bmp signalling in skeletal development, disease and repair. Nature Reviews Endocrinology, 12(4):203–221, February 2016. URL: http://dx.doi.org/10.1038/nrendo.2016.12, doi:10.1038/nrendo.2016.12. This article has 609 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrendo.2016.12)

[13. (Sammons2004The) J. Sammons, N. Ahmed, M. El-Sheemy, and H.T. Hassan. The role of bmp-6, il-6, and bmp-4 in mesenchymal stem cell–dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin d3. Stem Cells and Development, 13(3):273–280, June 2004. URL: http://dx.doi.org/10.1089/154732804323099208, doi:10.1089/154732804323099208. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/154732804323099208)

[14. (Bragdon2011Bone) Beth Bragdon, Oleksandra Moseychuk, Sven Saldanha, Daniel King, Joanne Julian, and Anja Nohe. Bone morphogenetic proteins: a critical review. Cellular Signalling, 23(4):609–620, April 2011. URL: http://dx.doi.org/10.1016/j.cellsig.2010.10.003, doi:10.1016/j.cellsig.2010.10.003. This article has 549 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2010.10.003)

[15. (Carreira2014Bone) Ana Claudia Carreira, Gutemberg Gomes Alves, William Fernando Zambuzzi, Mari Cleide Sogayar, and José Mauro Granjeiro. Bone morphogenetic proteins: structure, biological function and therapeutic applications. Archives of Biochemistry and Biophysics, 561:64–73, November 2014. URL: http://dx.doi.org/10.1016/j.abb.2014.07.011, doi:10.1016/j.abb.2014.07.011. This article has 141 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2014.07.011)